244 related articles for article (PubMed ID: 12239155)
21. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
22. CBFB and MYH11 in inv(16)(p13q22) of acute myeloid leukemia displaying close spatial proximity in interphase nuclei of human hematopoietic stem cells.
Weckerle AB; Santra M; Ng MC; Koty PP; Wang YH
Genes Chromosomes Cancer; 2011 Sep; 50(9):746-55. PubMed ID: 21638519
[TBL] [Abstract][Full Text] [Related]
23. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.
Castilla LH; Perrat P; Martinez NJ; Landrette SF; Keys R; Oikemus S; Flanegan J; Heilman S; Garrett L; Dutra A; Anderson S; Pihan GA; Wolff L; Liu PP
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4924-9. PubMed ID: 15044690
[TBL] [Abstract][Full Text] [Related]
24. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
[TBL] [Abstract][Full Text] [Related]
25. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
[TBL] [Abstract][Full Text] [Related]
26. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
Castilla LH; Bushweller JH
Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
[TBL] [Abstract][Full Text] [Related]
28. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
[TBL] [Abstract][Full Text] [Related]
30. Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.
Wunderlich M; Krejci O; Wei J; Mulloy JC
Blood; 2006 Sep; 108(5):1690-7. PubMed ID: 16670269
[TBL] [Abstract][Full Text] [Related]
31. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts.
van der Reijden BA; Lombardo M; Dauwerse HG; Giles RH; Mühlematter D; Bellomo MJ; Wessels HW; Beverstock GC; van Ommen GJ; Hagemeijer A
Blood; 1995 Jul; 86(1):277-82. PubMed ID: 7795233
[TBL] [Abstract][Full Text] [Related]
32. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of a new method for screening of CBFB-MYH11 fusion gene in acute myeloid leukemia and its value in clinical use].
Chen C; Li ZP; Lu QY; Liu ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1077-81. PubMed ID: 23114122
[TBL] [Abstract][Full Text] [Related]
34. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation.
Miller J; Horner A; Stacy T; Lowrey C; Lian JB; Stein G; Nuckolls GH; Speck NA
Nat Genet; 2002 Dec; 32(4):645-9. PubMed ID: 12434155
[TBL] [Abstract][Full Text] [Related]
35. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
Biernacki MA; Foster KA; Woodward KB; Coon ME; Cummings C; Cunningham TM; Dossa RG; Brault M; Stokke J; Olsen TM; Gardner K; Estey E; Meshinchi S; Rongvaux A; Bleakley M
J Clin Invest; 2020 Oct; 130(10):5127-5141. PubMed ID: 32831296
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
[TBL] [Abstract][Full Text] [Related]
37. Cbf beta is involved in maturation of all lineages of hematopoietic cells during embryogenesis except erythroid.
Kundu M; Liu PP
Blood Cells Mol Dis; 2003; 30(2):164-9. PubMed ID: 12732179
[TBL] [Abstract][Full Text] [Related]
38. The gene product of CBFB-MYH11.
Claxton D; Xie QS; Patel S; Deisseroth AB; Kornblau S
Leukemia; 1996 Sep; 10(9):1479-85. PubMed ID: 8751466
[TBL] [Abstract][Full Text] [Related]
39. The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis.
Duan W; Liu X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Zhao X; Qin Y; Shi H; Chang Y; Huang X; Jiang H
Br J Haematol; 2021 Jan; 192(2):265-271. PubMed ID: 32588434
[TBL] [Abstract][Full Text] [Related]
40. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]